000 01239 a2200373 4500
005 20250514053143.0
264 0 _c20030528
008 200305s 0 0 eng d
022 _a1465-3249
024 7 _a10.1080/146532402320776071
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHeslop, H E
245 0 0 _aImmune therapy for EBV infections after hemopoietic stem-cell transplant.
_h[electronic resource]
260 _bCytotherapy
_c2002
300 _a433-4 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntigens, CD20
_xmetabolism
650 0 4 _aClinical Trials as Topic
650 0 4 _aEpstein-Barr Virus Infections
_xtherapy
650 0 4 _aHematopoietic Stem Cell Transplantation
_xadverse effects
650 0 4 _aHerpesvirus 4, Human
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aLymphoma
_xvirology
700 1 _aBollard, C M
700 1 _aGottschalk, S
700 1 _aKuehnle, I
700 1 _aHuls, M H
700 1 _aGee, A P
700 1 _aBrenner, M K
700 1 _aRooney, C M
773 0 _tCytotherapy
_gvol. 4
_gno. 5
_gp. 433-4
856 4 0 _uhttps://doi.org/10.1080/146532402320776071
_zAvailable from publisher's website
999 _c12278183
_d12278183